Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -21.61% | 51.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.61% | 51.65% | |||
| Cost of Revenue | -3.50% | 2.10% | |||
| Gross Profit | -32.77% | 116.38% | |||
| SG&A Expenses | -44.47% | 136.71% | |||
| Depreciation & Amortization | 2.67% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.72% | 45.84% | |||
| Operating Income | 4.56% | 90.49% | |||
| Income Before Tax | 1.10% | 104.26% | |||
| Income Tax Expenses | -26.80% | 27.72% | |||
| Earnings from Continuing Operations | 16.39% | 204.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.39% | 204.57% | |||
| EBIT | 4.56% | 90.49% | |||
| EBITDA | 4.53% | 88.11% | |||
| EPS Basic | 0.00% | 209.28% | |||
| Normalized Basic EPS | -13.10% | 107.14% | |||
| EPS Diluted | 0.00% | 209.28% | |||
| Normalized Diluted EPS | -13.10% | 107.14% | |||
| Average Basic Shares Outstanding | 16.40% | -1.55% | |||
| Average Diluted Shares Outstanding | 16.40% | -1.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||